Cargando…
Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients
Nine hundred and eighty-four breast cancer patients were interviewed regarding exogenous hormonal use. This represents a random sample of breast cancer patients in Southern Sweden referred to the Department of Oncology at Lund for treatment between 1978 and 1997 (excluding 1980 and 1981) with a 100%...
Autores principales: | Jernström, H, Frenander, J, Fernö, M, Olsson, H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363064/ https://www.ncbi.nlm.nih.gov/pubmed/10424750 http://dx.doi.org/10.1038/sj.bjc.6690543 |
Ejemplares similares
-
Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families
por: Jernström, H, et al.
Publicado: (2005) -
Coffee intake and CYP1A2*1F genotype predict breast volume in young women: implications for breast cancer
por: Jernström, H, et al.
Publicado: (2008) -
Vascular grading of angiogenesis: prognostic significance in breast cancer
por: Hansen, S, et al.
Publicado: (2000) -
Hormone replacement therapy and risk of epithelial ovarian cancer
por: Purdie, D M, et al.
Publicado: (1999) -
Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis.
por: Borg, A., et al.
Publicado: (1991)